CAV1 and Hypertension: However, atherosclerosis and hypertension impair NO bioavailability due to lower eNOS expression, eNOS inactivation, changes in Cav-1 expression or NOX4 activity, and eNOS uncoupling, leading to deleterious ROS overproduction.